MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine"

  • 2025 International Congress

    Long-Term Effect of Dopaminergic Treatment on gait in De Novo Parkinson’s Disease: the DNA mobile health technology longitudinal study

    A. Pilotto, C. Zatti, A. Rizzardi, C. Hansen, J. Gerritz, R. Romijnders, M. Catania, A. Lupini, W. Maetzler, A. Padovani (Brescia, Italy)

    Objective: to evaluate the long-term effect of dopaminergic treatment on gait in Parkinson’s disease Background: monitoring the progression of Parkinson's disease (PD) and response to…
  • 2025 International Congress

    Subacute Severe Dystonia in a 19-month Old Boy. A Case of Pediatric Stiff Person Syndrome (SPS)

    MU. Huun, S. Wallace, SH. Nordstrand (Oslo, Norway)

    Objective: To report a rare case of anti-GAD associated encephalitis with pediatric Stiff Person Syndrome (SPS) highlighting the need for broad investigations and extensive treatment.…
  • 2025 International Congress

    Observations and Strategies for Improving Recruitment and Retention of Underrepresented Populations in Movement Disorders Clinical Research Trials Conducted in a Tertiary Research Site

    I. Saraf, P. Agarwal, L. Patron (Kirkland, USA)

    Objective: To observe the improvement in one tertiary clinical site of the recruitment of underrepresented populations with a focus on the Asian demographic and note…
  • 2025 International Congress

    Dual-task gait digital assessment unmask the association between dopaminergic deficits and gait parameters in early and prodromal Parkinson’s Disease

    A. Pilotto, C. Zatti, A. Rizzardi, A. Galli, C. Hansen, J. Geritz, R. Rominjnders, E. Schaeffer, M. Catania, A. Lupini, T. Comunale, E. Premi, M. Pasolini, S. Lucchini, F. Brertagna, B. Paghera, S. Caminiti, D. Perani, D. Berg, W. Maetzler, A. Padovani (Brescia, Italy)

    Objective: to explore the relationship between dopaminergic deficits and digital gait parameters alterations in de novo PD and iRBD Background: gait alterations are common features…
  • 2025 International Congress

    Evaluation of Neuroprotective Effect of Terminalia macroptera on Rotenone Induced Parkinson’s Disease in Mice

    L. Ior, E. Ishaya, P. Ezeuduji (Jos, Nigeria)

    Objective: This study investigates the neuroprotective effects of an aqueous extract of Terminalia macroptera (AETM) in a rotenone-induced Parkinsonism mouse model. Background: Parkinson’s disease (PD)…
  • 2025 International Congress

    The neuroprotective effects of Echinacoside on α-synuclein fibril-induced Parkinson’s disease mice model

    Q. Zhao, S. Bu, Z. Wang, L. Jin (Shanghai, China)

    Objective: This study further investigates the ameliorative effects of ECH on neurobehavioral abnormalities and nigrostriatal dopaminergic system impairment in α-synuclein preformed fibrils (α-Syn PFFs)-induced PD…
  • 2025 International Congress

    Chronic DBS Stimulation’s effects after 1-hour off stimulation

    M. Varga, Y. Zhao, S. Santacruz (Austin, USA)

    Objective: This study investigates the changes in local field potential (LFP) activity during chronic deep brain stimulation (DBS) in patients with Parkinson's disease (PD) during…
  • 2025 International Congress

    Cognitive and Neuropsychiatric Dysfunction is Associated with Corticostriatal Synucleinopathy in the Alpha-Synuclein Preformed Fibril Rat Model of Parkinson’s Disease

    J. Bechtold, J. Patterson, C. Kemp, A. Stoll, S. Arrington, M. Venard, L. Mayle, V. Field, J. Holden, C. Sortwell, S. Fleming (Rootstown, USA)

    Objective: To investigate the role of corticostriatal synucleinopathy on behavioral function in an alpha-synuclein preformed fibril (a-Syn PFF) rat model of Parkinson’s disease (PD). Background:…
  • 2025 International Congress

    The efficacy and safety of continuous subcutaneous infusion therapy with foslevodopa/foscarbidopa

    M. Shiraishi, N. Takao, Y. Nakano, Y. Yamano (Kawasaki City, Japan)

    Objective: To clarify the actual status of CSCI therapy, cases in which CSCI therapy was started at our hospital were investigated. Background: Continuous subcutaneous infusion…
  • 2025 International Congress

    A Biomarker-Directed Approach to the Early Diagnosis of Parkinson’s Disease Using Artificial Intelligence and Machine Learning

    ME. Mellaci (SÃO PAULO, Brazil)

    Objective: The main purpose of this study was to assess how AI and ML methods integrate multiple biomarkers for diagnosing Parkinson’s Disease (PD) to improve…
  • 1
  • 2
  • 3
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley